phosphatidylcholines has been researched along with celastrol in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 885 | 1 | 741 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | celastrol (IC50) |
|---|---|---|---|
| Telomerase reverse transcriptase | Homo sapiens (human) | 0.78 | |
| Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Homo sapiens (human) | 6.8 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 8.41 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | 6.8 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.45 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.1 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.5667 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.25 | |
| Regulator of G-protein signaling 17 | Homo sapiens (human) | 6.1795 | |
| Ubiquitin carboxyl-terminal hydrolase 15 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Homo sapiens (human) | 6.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, FJ; Hu, D; Li, F; Xiao, X; Yang, R; Zhang, T; Zhao, Q; Zhu, X | 1 |
1 other study(ies) available for phosphatidylcholines and celastrol
| Article | Year |
|---|---|
Modulation of Lipid Metabolism by Celastrol.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; 3T3-L1 Cells; Adipocytes; Animals; Cell Differentiation; Diet, High-Fat; Gene Expression Regulation; Humans; Hyperlipidemias; Lipid Metabolism; Liver; Lysophosphatidylcholines; Mice; Pentacyclic Triterpenes; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipase D; Polyethylene Glycols; Proteasome Inhibitors; Sphingomyelin Phosphodiesterase; Sphingomyelins; Triterpenes | 2019 |